108 related articles for article (PubMed ID: 7666456)
1. It's not easy being green: chlorophyll being tested.
Ziegler J
J Natl Cancer Inst; 1995 Jan; 87(1):11. PubMed ID: 7666456
[No Abstract] [Full Text] [Related]
2. [Anticarcinogenic action of dietary supplement pheocarpin and its active component].
Bespalov VG; Aleksandrov VA; Petrov AS
Vopr Onkol; 2006; 52(2):169-74. PubMed ID: 17195642
[TBL] [Abstract][Full Text] [Related]
3. Translational research on TNF-alpha as an endogenous tumor promoter and green tea as cancer preventive in humans.
Fujiki H; Suganuma M
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):3-30. PubMed ID: 16304719
[No Abstract] [Full Text] [Related]
4. Naturally occurring chlorophyll derivatives inhibit aflatoxin B1-DNA adduct formation in hepatoma cells.
Hsu CY; Chen YH; Chao PY; Chen CM; Hsieh LL; Hu SP
Mutat Res; 2008 Dec; 657(2):98-104. PubMed ID: 18775795
[TBL] [Abstract][Full Text] [Related]
5. Clinical development plan: 1,4-penylenebis(methylene)selenocyanate.
J Cell Biochem Suppl; 1996; 26():219-26. PubMed ID: 9154179
[No Abstract] [Full Text] [Related]
6. Clinical development plan: (+)-vorozole.
J Cell Biochem Suppl; 1996; 26():308-15. PubMed ID: 9154184
[No Abstract] [Full Text] [Related]
7. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
[No Abstract] [Full Text] [Related]
8. Clinical development plan: sulindac sulfone.
J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
[No Abstract] [Full Text] [Related]
9. Antimutagenesis and anticancer effects.
Bronzetti G; Della Croce C; Aretini P; Fiorio R
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):59-64. PubMed ID: 9216786
[TBL] [Abstract][Full Text] [Related]
10. Clinical development plan: 13-cis-retinoic acid.
J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
[No Abstract] [Full Text] [Related]
11. Clinical development plan: vitamin A.
J Cell Biochem Suppl; 1996; 26():269-307. PubMed ID: 9154183
[No Abstract] [Full Text] [Related]
12. Clinical development plan: dehydroepiandrosterone (DHEA).
J Cell Biochem Suppl; 1996; 26():86-99. PubMed ID: 9154170
[No Abstract] [Full Text] [Related]
13. Clinical development plan: phenethyl isothiocyanate.
J Cell Biochem Suppl; 1996; 26():149-57. PubMed ID: 9154175
[No Abstract] [Full Text] [Related]
14. [Anticarcinogenic activity of carotenoids].
Sherenesheva NI
Vopr Pitan; 1993; (4):13-7. PubMed ID: 8073687
[No Abstract] [Full Text] [Related]
15. Tea antioxidants in cancer chemoprevention.
Katiyar SK; Mukhtar H
J Cell Biochem Suppl; 1997; 27():59-67. PubMed ID: 9591194
[TBL] [Abstract][Full Text] [Related]
16. Clinical development plan: genistein.
J Cell Biochem Suppl; 1996; 26():114-26. PubMed ID: 9154172
[No Abstract] [Full Text] [Related]
17. Clinical development plan: 9-cis-retinoic acid.
J Cell Biochem Suppl; 1996; 26():158-67. PubMed ID: 9154176
[No Abstract] [Full Text] [Related]
18. It's Not Easy Not Being Green: Breakthroughs in Chlorophyll Breakdown.
Mach J
Plant Cell; 2016 Oct; 28(10):2350-2351. PubMed ID: 27670671
[No Abstract] [Full Text] [Related]
19. Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects.
Linkov I; Wilson R; Gray GM
Toxicol Sci; 1998 May; 43(1):1-9. PubMed ID: 9629614
[TBL] [Abstract][Full Text] [Related]
20. Clinical development plan: curcumin.
J Cell Biochem Suppl; 1996; 26():72-85. PubMed ID: 9154169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
